PMID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40659634,Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response.,2025-Jul-14,"['Wesley Sukdao', 'Steven Walsh', 'Emma V Yates']","['Proteotype Diagnostics Ltd, Babraham Research Campus, Cambridge, UK.', 'Proteotype Diagnostics Ltd, Babraham Research Campus, Cambridge, UK.', 'Proteotype Diagnostics Ltd, Babraham Research Campus, Cambridge, UK. emma@proteotype.com.']",emma@proteotype.com
40658815,Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer.,2025-Jul-14,"['Hyun Young Shin', 'Jungmin Lee']","['CTCELLS Inc., Seoul 06307, Republic of Korea.', 'CTCELLS Inc., Seoul 06307, Republic of Korea.']",
40657937,"Advancing Predictions of Oral Drug Absorption, CYP3A4 Induction, and Transporter-Mediated Interactions Using a Human Primary Intestinal 3D Model (EpiIntestinalâ„¢).",2025-Jul-14,"['Paresh P Chothe', 'Andrea Whitcher-Johnstone', 'Aniruddha Karve', 'Diane Ramsden', 'Niresh Hariparsad']","['Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca, Waltham, Massachusetts, USA.', 'Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca, Waltham, Massachusetts, USA.', 'Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca, Waltham, Massachusetts, USA.', 'Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca, Waltham, Massachusetts, USA.', 'Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca, Waltham, Massachusetts, USA.']",
40657894,Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2- Metastatic Breast Cancer Data From the Phase 3 TROPiCS-02 Trial.,2025-Jul,"['Paul M Diderichsen', 'Xiaohui Wang', 'Peter Chang']","['Integrated Drug Development Consulting, Certara USA, Inc., Radnor, Pennsylvania, USA.', 'Integrated Drug Development Consulting, Certara USA, Inc., Radnor, Pennsylvania, USA.', 'Integrated Drug Development Consulting, Certara USA, Inc., Radnor, Pennsylvania, USA.']",
